[go: up one dir, main page]

ATE179754T1 - Verfahren zur herstellung von thrombin - Google Patents

Verfahren zur herstellung von thrombin

Info

Publication number
ATE179754T1
ATE179754T1 AT93902869T AT93902869T ATE179754T1 AT E179754 T1 ATE179754 T1 AT E179754T1 AT 93902869 T AT93902869 T AT 93902869T AT 93902869 T AT93902869 T AT 93902869T AT E179754 T1 ATE179754 T1 AT E179754T1
Authority
AT
Austria
Prior art keywords
thrombin
host cells
produced
transfected
transformed
Prior art date
Application number
AT93902869T
Other languages
English (en)
Inventor
Richard D Holly
Donald C Foster
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE179754T1 publication Critical patent/ATE179754T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT93902869T 1991-12-31 1992-12-30 Verfahren zur herstellung von thrombin ATE179754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81628191A 1991-12-31 1991-12-31
US86070192A 1992-03-31 1992-03-31

Publications (1)

Publication Number Publication Date
ATE179754T1 true ATE179754T1 (de) 1999-05-15

Family

ID=27124054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902869T ATE179754T1 (de) 1991-12-31 1992-12-30 Verfahren zur herstellung von thrombin

Country Status (13)

Country Link
US (2) US5476777A (de)
EP (1) EP0624199B1 (de)
JP (1) JP3404038B2 (de)
AT (1) ATE179754T1 (de)
AU (1) AU683834B2 (de)
CA (1) CA2125783C (de)
DE (1) DE69229126T2 (de)
DK (1) DK0624199T3 (de)
ES (1) ES2134836T3 (de)
FI (1) FI117831B (de)
GR (1) GR3030820T3 (de)
NO (1) NO317018B1 (de)
WO (1) WO1993013208A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010322A1 (en) * 1992-10-29 1994-05-11 Board Of Regents, The University Of Texas System Adenovirus-mediated ldl receptor gene transfer and targeting
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
EP0993311B1 (de) * 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Thrombin und mikrofibrillares collagen enthaltene zusammensetzung sowie herstellungsmethoden und dessen gebrauch
US20030207402A1 (en) * 1997-08-22 2003-11-06 Erhard Kopetzki Autocatalytically activatable zymogenic precursors of proteases and their use
EP1061931A2 (de) * 1998-03-10 2000-12-27 Baxter International Inc. Thrombinpräparation und produkte, sowie verschlussverfahren auf fibrinbasis unter verwendung derselben
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors
US20030096771A1 (en) * 2001-07-26 2003-05-22 Butler Madeline M. Antisense modulation of hormone-sensitive lipase expression
KR20000018933A (ko) * 1998-09-07 2000-04-06 김승수 내피세포 성장억제 활성을 가지는 사람 프로트롬빈 크링글단백질 및 이를 암호하는 유전자
IL129427A0 (en) * 1999-04-13 2000-02-17 Yeda Res & Dev Preparation of biologically active molecules
AU6913600A (en) * 1999-08-19 2001-03-13 Us Transgenics, Inc. Transgenic prothrombin and related thrombin precursors and transgenics, methods,compositions, uses and the like relating thereto
KR20040080940A (ko) * 2001-05-14 2004-09-20 덴드레온 코포레이션 트랜스막 세린 프로테아제 10을 암호화하는 핵산 분자,암호화된 폴리펩티드 및 이에 근거한 방법
US7772459B2 (en) 2002-02-20 2010-08-10 Bellweather Farms Transgenic production in saliva
US20030175410A1 (en) * 2002-03-18 2003-09-18 Campbell Phil G. Method and apparatus for preparing biomimetic scaffold
US20100254900A1 (en) * 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8293530B2 (en) * 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
ES2226587B1 (es) 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US20060270014A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US7825231B2 (en) * 2005-06-01 2010-11-02 Darren P. Wolfe Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
EP2093256A3 (de) 2005-07-28 2009-10-14 Carnegie Mellon University Biokompatible Polymere und Verwendungsverfahren
WO2007040162A1 (ja) 2005-09-30 2007-04-12 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 培養細胞による組換えヒトトロンビンの製造方法
CA2644926A1 (en) 2006-03-06 2007-09-13 Humagene, Inc. A method for the preparation of recombinant human thrombin and fibrinogen
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
WO2008092656A1 (en) * 2007-01-31 2008-08-07 Anders Jeppsson Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion
AU2008296206A1 (en) * 2007-09-05 2009-03-12 Zymogenetics, Inc. Mass spectrometry-based quantitative assay for determining abundance of molecular species in a composition
CA2721462C (en) * 2008-04-25 2019-02-05 Zymogenetics, Inc. Medical devices for delivering fluids during surgery and methods for their use
RU2015135227A (ru) 2013-01-22 2018-12-25 Кенкор Биотех Лтд. Способ получения рекомбинантного человеческого протромбина и фибриногена
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910005081B1 (ko) * 1988-09-23 1991-07-22 삼성전관 주식회사 칼라브라운관의 형광면 제작방법
DE69101634D1 (de) * 1990-01-26 1994-05-11 Immuno Ag Wien Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
ES2131504T3 (es) * 1990-02-20 1999-08-01 Baxter Int Trombina humana purificada viricamente segura.

Also Published As

Publication number Publication date
US5476777A (en) 1995-12-19
FI943122A0 (fi) 1994-06-29
CA2125783A1 (en) 1993-07-08
AU3428793A (en) 1993-07-28
GR3030820T3 (en) 1999-11-30
WO1993013208A1 (en) 1993-07-08
NO942456D0 (no) 1994-06-29
ES2134836T3 (es) 1999-10-16
JP3404038B2 (ja) 2003-05-06
FI117831B (fi) 2007-03-15
JPH07502659A (ja) 1995-03-23
NO942456L (no) 1994-06-29
NO317018B1 (no) 2004-07-26
DE69229126D1 (de) 1999-06-10
DE69229126T2 (de) 1999-12-30
FI943122L (fi) 1994-06-29
EP0624199A1 (de) 1994-11-17
EP0624199B1 (de) 1999-05-06
AU683834B2 (en) 1997-11-27
US5502034A (en) 1996-03-26
CA2125783C (en) 2003-03-25
DK0624199T3 (da) 1999-11-01

Similar Documents

Publication Publication Date Title
ATE179754T1 (de) Verfahren zur herstellung von thrombin
ATE258189T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
AU6801487A (en) Method of producing a recombinant protein complex having human factor VIII:C activity
FI862756A0 (fi) Fibroektiner.
ATE90966T1 (de) Expression von protein-c.
ATE206164T1 (de) Rekombinante herstellung von neuen polyketiden
ES8800343A1 (es) Un metodo para producir una proteina que contiene actividad biologica para coagulacion de sangre, mediada por factor viia
DE60142226D1 (de) Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
DE68925083D1 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
YU128789A (sh) Postupak za dobijanje područja alkoholne oksidaze ii pichia pastoris-a
DE3682891D1 (de) Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DK0567503T3 (da) Gen for Pasteurella haemolytica glycoprotease, samt det rensede enzym.
DK0749489T3 (da) Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe
ATE118817T1 (de) Verfahren zur herstellung von xbai- restriktionsendonuklease und -methylase.
DE3687948D1 (de) Verfahren und nukleinsaeure zur herstellung von lecithin: cholestrinacyltransferase.
HUP9701904A2 (hu) D-panolakton hidroláz és az azt kódoló gén
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
DE3585416D1 (de) Verfahren zur herstellung eines biologischen stoffes.
NL960017I1 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
ATE118816T1 (de) Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase.
DE69104357D1 (de) Klonierungs- und/oder expressionsvektoren, verfahren zur ihrer herstellung und verwendung.
DE3668166D1 (de) Verfahren zur herstellung von alkylarylethern.
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.
ATE98967T1 (de) Verfahren zur herstellung von polyharnstoffpolyurethanweichschaeumen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification